top of page
  • Writer's pictureBert Grobben

Agile Transformation in the Health industry - StartUp mixer with ROCHE

WHAT: Informal gathering of Health enthusiasts and experts to share applied insights and approaches to transform company wide organisations to become more agile. In Asia, 30 ROCHE executives are going through a journey of translating a centrally lead company strategy, into a regional implementation. With this implementation, there is an opportunity to take local needs and flavours into account, and learn from current best practices to serve as inspiration for ROCHE During this (free) event, we bring people passionate in health, transformation, agile operations, etc. together with the ROCHE team, and have a conversation around what it takes to transform organisations and operations. WHEN: October 31st, 2019 WHERE: JustCo Co-Working space at Marine Square (6 Raffles Boulevard) AGENDA: 5:30pm : Welcome address 5:35pm : Opening by ROCHE 5:45pm - 6:10pm : Start-up introductions (2min each) 6:10pm - 7:30pm : Share & Reapply discussion with 30 ROCHE executives on applied Agile Transformation. Register: About ROCHE: ROCHE has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. ROCHE was one of the first companies to bring targeted treatments to patients. With its combined strength in pharmaceuticals and diagnostics, ROCHE is better equipped than any other company to further drive personalised healthcare. Two-thirds of its Research and Development projects are being developed with companion diagnostics. ROCHE is the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in its product pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. ROCHE has been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers. ROCHE offers doctors profound information to guide treatments and to answer more patients’ questions than any other company. And its tests enable hospitals and labs to deliver that information quickly and reliably. ROCHE invests around 9 billion Swiss francs in Research and Development every year because innovation is its lifeblood. This is amongst the highest Research and Development spends in the world across all industries. ROCHE is a force of over 90,000 people working together across more than 100 countries. Roche is consistently ranked as employer of choice by its employees and by external institutions. For many years running ROCHE has been recognized by the Dow Jones Sustainability Indices as the leader in sustainability within its industry.

8 views0 comments
bottom of page